Bharat Parenterals Peer Comparison

BSE: 541096

₹1,819.00

₹18.40 (1.02%)

As on 05-Nov-2026IST

Market cap

₹1,282 Cr

Revenue (TTM)

₹395 Cr

P/E Ratio

1029.8

P/B Ratio

3.9

Div. Yield

0.1 %

Edit

	Bharat Parenterals	Pfizer	Eris Lifesciences	CORONA Remedies	Strides Pharma
Market cap (₹ Cr)	1,282	17,679	17,062	14,667	9,236
Revenue (₹ Cr)	395	2,654	3,330	1,559	5,213
Net Profit (₹ Cr)	-9.58	859.38	720.77	206.58	635.98
Net Margin (%)	-2.37	30.42	21.60	13.15	11.92
RoE (%)	0.38	18.58	18.93	28.52	17.69
Price to Earnings	1,029.78	20.57	24.11	70.85	14.97
Price-To-Book	3.86	4.03	4.12	18.22	2.70

Income Statement (₹ Cr)

	Bharat Parenterals	Pfizer	Eris Lifesciences	CORONA Remedies	Strides Pharma
Operating Revenue	394.83	2,654.29	3,329.63	1,559.11	5,213.26
Total Income	403.44	2,825.39	3,337.47	1,571.09	5,337.22
Total Expenditure	361.50	1,681.39	2,168.88	1,224.85	4,256.92
EBITDA	33.34	972.90	1,160.75	334.26	956.34
Depreciation	34.78	57.71	285.40	48.04	217.49
EBIT	-1.45	915.19	875.35	286.22	738.85
Interest	11.31	8.91	187.51	8.48	172.06
Other Income	8.61	171.10	7.84	11.98	123.96
Exceptional Items	0.00	82.90	-53.14	-19.10	51.79
Profit before Tax	-4.15	1,160.28	642.54	270.62	742.55
Provision for Tax	5.42	300.90	-78.23	64.04	106.56
Profit after Tax	-9.58	859.38	720.77	206.58	635.98

	Bharat Parenterals	Pfizer	Eris Lifesciences	CORONA Remedies	Strides Pharma
Shareholder's Funds	332.14	4,385.41	4,144.34	804.07	3,416.47
Minority Interest	10.82	0.00	-10.85	0.00	-20.21
Non-Current Liabilities	151.30	222.21	758.48	108.63	883.34
Current Liabilities	192.98	685.36	2,681.14	333.00	3,134.98
Total Liabilities	620.18	4,921.88	7,246.72	--	6,806.56

	Bharat Parenterals	Pfizer	Eris Lifesciences	CORONA Remedies	Strides Pharma
Non-Current Assets	340.73	905.21	5,578.78	719.39	3,199.94
Current Assets	294.51	4,024.56	1,800.86	473.68	4,037.16
Total Assets	620.18	4,921.88	7,246.72	--	6,806.56
Total Debt*	146.11	2.50	2,309.68	--	1,668.69
Net Current Assets	101.53	3,339.20	-880.28	140.68	902.19
Contingent Liabilities	21.52	370.49	51.57	--	118.51

	Bharat Parenterals	Pfizer	Eris Lifesciences	CORONA Remedies	Strides Pharma
Cash From Operating Activities	38.36	967.57	537.99	--	702.52
Cash Flow from Investing Activities	9.32	-561.67	-369.46	--	-173.04
Cash from Financing Activities	-47.05	-798.31	-313.53	--	-453.41
Net Cash Inflow / Outflow	0.64	-392.41	-145.00	--	76.07

	Bharat Parenterals	Pfizer	Eris Lifesciences	CORONA Remedies	Strides Pharma
ROCE (%)	-1.82	23.39	14.47	--	18.57
ROE (%)	0.38	18.58	18.93	28.50	17.69
ROA (%)	-1.55	17.36	9.78	18.60	9.08
EBIT Margin (%)	-0.37	34.48	26.29	18.36	14.17
Net Margin (%)	-2.37	30.42	21.60	13.15	11.92
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Bharat Parenterals	Pfizer	Eris Lifesciences	CORONA Remedies	Strides Pharma
Revenue Growth (%)	10.64	11.75	11.06	20.02	11.28
EBIT Growth (%)	89.65	21.45	13.71	22.30	8.34
Net Profit Growth (%)	64.25	2.39	60.98	18.28	55.25
EPS Growth (%)	123.00	13.17	80.38	26.45	32.65
Book Value Growth (%)	-2.55	-0.34	36.71	--	21.78

	Bharat Parenterals	Pfizer	Eris Lifesciences	CORONA Remedies	Strides Pharma
Price / Earnings	999.58	21.98	22.11	66.45	16.16
Price / Book Value	3.74	3.98	4.08	18.25	2.73
Dividend Yield (%)	0.06	1.96	0.00	0.42	0.49
EV/EBITDA	41.12	14.83	16.48	44.20	11.28
Market Cap (₹ Cr)	620.46	21,592.90	17,980.08	--	8,643.60

	Bharat Parenterals	Pfizer	Eris Lifesciences	CORONA Remedies	Strides Pharma
Debt to Equity	0.38	0.00	0.10	0.00	0.17
Short term debt to equity ratio	0.05	0.00	0.12	--	0.33
Current Ratio	1.53	5.87	0.67	1.42	1.29
Quick Ratio	1.09	5.23	0.49	0.91	0.69
Interest Coverage	0.63	131.22	4.43	32.91	5.32

	Bharat Parenterals	Pfizer	Eris Lifesciences	CORONA Remedies	Strides Pharma
Debtors to sales (%)	34.82	9.10	18.98	10.94	28.08
Asset Turnover	0.64	0.54	0.45	1.40	0.74
Receivable days	170.08	26.06	63.88	--	64.34
Inventory Days	82.65	65.95	43.27	--	75.20
Payable days	131.69	81.01	151.85	--	218.23
Cash Conversion Cycle	121.04	11.00	-44.70	--	-78.69

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.